Global Cord Blood (NYSE:CO) Announces Quarterly Earnings Results

Global Cord Blood (NYSE:CO) posted its quarterly earnings data on Tuesday. The medical research company reported $0.13 earnings per share for the quarter, Morningstar.com reports. The business had revenue of $39.82 million during the quarter. Global Cord Blood had a net margin of 31.78% and a return on equity of 9.72%.

CO stock opened at $4.34 on Friday. The company has a market capitalization of $559.14 million, a P/E ratio of 11.80 and a beta of 0.20. The company has a 50-day simple moving average of $5.54 and a 200 day simple moving average of $6.39. Global Cord Blood has a fifty-two week low of $4.24 and a fifty-two week high of $7.73.

Hedge funds and other institutional investors have recently modified their holdings of the business. BlackRock Inc. lifted its holdings in Global Cord Blood by 2,935.0% in the 4th quarter. BlackRock Inc. now owns 7,284 shares of the medical research company’s stock valued at $47,000 after acquiring an additional 7,044 shares during the last quarter. Lingohr & Partner Asset Management GmbH acquired a new stake in Global Cord Blood in the 1st quarter valued at about $422,000. Parametric Portfolio Associates LLC lifted its holdings in Global Cord Blood by 20.3% in the 2nd quarter. Parametric Portfolio Associates LLC now owns 94,469 shares of the medical research company’s stock valued at $546,000 after acquiring an additional 15,934 shares during the last quarter. SG Americas Securities LLC acquired a new stake in Global Cord Blood in the 1st quarter valued at about $758,000. Finally, Quinn Opportunity Partners LLC lifted its holdings in Global Cord Blood by 2.3% in the 2nd quarter. Quinn Opportunity Partners LLC now owns 259,764 shares of the medical research company’s stock valued at $1,501,000 after acquiring an additional 5,800 shares during the last quarter. 16.94% of the stock is owned by institutional investors.

About Global Cord Blood

Global Cord Blood Corporation, together with its subsidiaries, provides umbilical cord blood storage and ancillary services in the People's Republic of China. The company offers cord blood testing, processing, and storage services under the direction of subscribers; and tests, processes, and stores donated cord blood, as well as provides matching services.

Recommended Story: Mutual funds are not immune from market timing

Earnings History for Global Cord Blood (NYSE:CO)

Receive News & Ratings for Global Cord Blood Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Global Cord Blood and related companies with MarketBeat.com's FREE daily email newsletter.